Table 2.
Results platelet activation
| |
Controls |
CKD |
P-value |
P-value |
|---|---|---|---|---|
| N = 19 | N = 23 | Adjusted for age | ||
| Maximal MFI TRAP, AU (IQR) |
11.4 (9.2-12.2) |
9.7 (7.9-10.8) |
0.032 |
0.095 |
| Maximal MFI ADP, AU (IQR) |
2.6 (1.9-3.5) |
1.6 (1.2-2.1) |
0.002 |
0.004 |
| Maximal MFICRP, AU (IQR) |
11.5 (9.5-12.9) |
9.2 (8.5-10.8) |
0.004 |
0.010 |
| EC50 TRAP, μM (IQR) |
1.9 (1.5-2.5) |
2.3 (1.8-2.6) |
0.372 |
0.182 |
| EC50 ADP, μM (IQR) |
0.9 (0.6-1.1) |
0.89 (0.7-1.1) |
0.544 |
0.597 |
| EC50 CRP, ng/ml (IQR) |
120 (46.7-312.7) |
116.1 (46.1-270.5) |
0.955 |
0.660 |
| AUC TRAP, AU (IQR) |
47.1 (41.1-54.2) |
39.5 (32.9-44.4) |
0.012 |
0.023 |
| AUC ADP, AU (IQR) |
8.9 (7.9-12.2) |
5.8 (3.8-7.3) |
0.002 |
0.003 |
| AUC CRP, AU (IQR) | 30.3 (22.1-41.9) | 23.4 (18.9-34.7) | 0.063 | 0.322 |
MFI Mean fluorescence intensity, AU arbitrary units, IQR inter quartile range, EC50 concentration of agonist leading to a half maximal P-selectin expression, AUC Area under the curve.